Schedules of Controlled Substances: Placement of Furanyl Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl, Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I; Correction

Citation84 FR 20023
Record Number2019-09477
Published date08 May 2019
SectionRules and Regulations
CourtDrug Enforcement Administration
Federal Register, Volume 84 Issue 89 (Wednesday, May 8, 2019)
[Federal Register Volume 84, Number 89 (Wednesday, May 8, 2019)]
                [Rules and Regulations]
                [Page 20023]
                From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
                [FR Doc No: 2019-09477]
                =======================================================================
                -----------------------------------------------------------------------
                DEPARTMENT OF JUSTICE
                Drug Enforcement Administration
                21 CFR Part 1308
                [Docket No. DEA-490]
                Schedules of Controlled Substances: Placement of Furanyl
                Fentanyl, 4-Fluoroisobutyryl Fentanyl, Acryl Fentanyl,
                Tetrahydrofuranyl Fentanyl, and Ocfentanil in Schedule I; Correction
                AGENCY: Drug Enforcement Administration, Department of Justice.
                ACTION: Final rule; correcting amendment.
                -----------------------------------------------------------------------
                SUMMARY: The Drug Enforcement Administration is correcting a final
                order that appeared in the Federal Register on November 29, 2018. The
                document issued an action maintaining the placement of furanyl
                fentanyl, 4-fluoroisobutyryl fentanyl, acryl fentanyl,
                tetrahydrofuranyl fentanyl, and ocfentanil, including their isomers,
                esters, ethers, salts, and salts of isomers, esters and ethers, in
                schedule I of the Controlled Substances Act. A drafting oversight in
                the amendatory instructions did not correctly update the prefatory
                language on isomers to reflect the change in the paragraph number for
                the designation of 3-methylthiofentanyl.
                DATES: Effective Date: May 8, 2019.
                FOR FURTHER INFORMATION CONTACT: Lynnette M. Wingert, Diversion Control
                Division, Drug Enforcement Administration; Mailing Address: 8701
                Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598-
                6812.
                SUPPLEMENTARY INFORMATION: On May 29, 1987, the Drug Enforcement
                Administration (DEA) placed six substances, including 3-
                methylthiofentanyl, into schedule I of the Controlled Substances Act.
                52 FR 20070. At that time, the introductory text was revised to clearly
                indicate that optical and geometric isomers of 3-methylthiofentanyl
                were controlled. On January 8, 1988, paragraph (b)(34), the listing for
                3-methylthiofentanyl, was redesignated to (b)(35), but the introductory
                text was not revised. 53 FR 500. On May 16, 2016, paragraph (b)(35),
                the listing for 3-methylthiofentanyl, was redesignated to (b)(36), but
                the introductory text was not revised. 81 FR 22023. On June 7, 2017,
                paragraph (b)(36), the listing for 3-methylthiofentanyl, was
                redesignated to (b)(37), but the introductory text was not revised. 82
                FR 26349. On April 20, 2018, paragraph (b)(37), the listing for 3-
                methylthiofentanyl, was redesignated to (b)(38), but the introductory
                text was not revised. 83 FR 17486. On November 29, 2018, paragraph
                (b)(38), the listing for 3-methylthiofentanyl, was redesignated to
                (b)(41), the present listing for 3-methylthiofentanyl, and a further
                error was introduced by modifying the reference to (b)(34) in the
                preamble to (b)(39), due to a drafting fault. 83 FR 61320.
                 Previously, the prefatory language has identified 3-
                methylthiofentanyl by paragraph number. However, the paragraph numbers
                have changed frequently over time, as new substances are identified and
                added to the list of schedule I substances in Sec. 1308.11(b). In
                order to avoid similar oversights or confusion in the future, this
                correction changes the designation to reference 3-methylthiofentanyl by
                name rather than by paragraph number.
                 Because this final rule is limited to a technical correction for
                accuracy and does not substantively alter any regulation, and is
                therefore insignificant in nature and impact, and inconsequential to
                the public, the Agency finds good cause that notice and public
                procedure are unnecessary to the promulgation of this correction. 5
                U.S.C. 553(b)(B). The Agency also finds that this technical correction
                merely clarifies or explains the existing regulation and is therefore
                an interpretive rule that does not require notice and comment
                rulemaking. 5 U.S.C. 553(b)(A); see also Reno-Sparks Indian Colony v.
                EPA, 336 F.3d 899, 909-10 (9th Cir. 2003) (stating that a Technical
                Correction ``was interpretive because it does not change existing
                substantive law'' and thus could be promulgated ``by foregoing notice
                and comment procedures'').
                 Because, as described above, this final rule is limited to a
                technical correction for accuracy and does not substantively alter any
                regulation, and is therefore insignificant in nature and impact, and
                inconsequential to the public, the Agency finds good cause to make this
                final rule effective upon the date of publication and to forego thirty
                days prior notice. See 5 U.S.C. 553(d)(3). In addition, pursuant to 5
                U.S.C. 553(d)(2), interpretive rules do not require thirty days prior
                notice before they may become effective. Therefore, because this
                technical correction is an interpretive rule, it may be made effective
                immediately. 5 U.S.C. 553(d)(2).
                List of Subjects in 21 CFR Part 1308
                 Administrative practice and procedure, Drug traffic control,
                Reporting and recordkeeping requirements.
                 For the reasons set out above, 21 CFR part 1308 is amended as
                follows:
                PART 1308--SCHEDULES OF CONTROLLED SUBSTANCES
                0
                1. The authority citation for part 1308 continues to read as follows:
                 Authority: 21 U.S.C. 811, 812, 871(b), 956(b), unless otherwise
                noted.
                0
                2. Revise the introductory text of Sec. 1308.11(b) to read as follows:
                Sec. 1308.11 Schedule I.
                * * * * *
                 (b) Opiates. Unless specifically excepted or unless listed in
                another schedule, any of the following opiates, including their
                isomers, esters, ethers, salts, and salts of isomers, esters and
                ethers, whenever the existence of such isomers, esters, ethers and
                salts is possible within the specific chemical designation (for
                purposes of 3-methylthiofentanyl only, the term isomer includes the
                optical and geometric isomers):
                * * * * *
                 Dated: May 3, 2019.
                Uttam Dhillon,
                Acting Administrator.
                [FR Doc. 2019-09477 Filed 5-7-19; 8:45 am]
                 BILLING CODE 4410-09-P
                

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT